Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial
- Submitting institution
-
The University of Westminster
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- qy633
- Type
- D - Journal article
- DOI
-
10.1016/S0140-6736(19)32518-8
- Title of journal
- Lancet
- Article number
- -
- First page
- 2263
- Volume
- 394
- Issue
- 10216
- ISSN
- 0140-6736
- Open access status
- Compliant
- Month of publication
- December
- Year of publication
- 2019
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
17
- Research group(s)
-
-
- Citation count
- 14
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- Author undertook all of the analysis of the TGF-beta for this study. This involved laboratory analysis in the sample set along with data analysis and interpretation with the research group and providing the writing aspect of the TGF-b methodology for the paper as well further review of the paper.
- Non-English
- No
- English abstract
- -
